首页> 外文期刊>Herz >Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients
【24h】

Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients

机译:galectin-3与慢性血液透析患者左室几何结构和肥大的关系

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim and background. Galectin-3 (Gal-3) is used to determine the prognosis of heart failure. Some studies revealed that Gal-3 promoted cardiac hypertrophy but there is no study in which the relationship between -Gal-3 and left ventricular hypertrophy (LVH) geometry in patients without diastolic and systolic function impairment has been explored. The aim of the study was to analyze associations between plasma Gal-3 levels, LVH, and LV geometry in maintenance hemodialysis (HD) patients without systolic and diastolic dysfunction.
机译:目的和背景。 Galectin-3(Gal-3)用于确定心力衰竭的预后。一些研究表明,Gal-3可促进心脏肥大,但尚无研究探讨无舒张和收缩功能受损的患者中-Gal-3与左心室肥大(LVH)几何形状之间的关系。该研究的目的是分析没有收缩压和舒张功能障碍的维持性血液透析(HD)患者血浆Gal-3水平,LVH和LV几何形状之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号